Revance Therapeutics Inc.
H‑1B Sponsor Verified
Revance Therapeutics Inc. filed 16 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2021–2023. Its most recent filings were in 2023, so check current sponsorship with the company. The average H-1B salary is $129,659 and the most sponsored role is Clinical Research Associate.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Jul 17, 2023.
LinkedIn ↗Latest Year Filings
1
In 2023
↗ Filter by year
Total H‑1B Filings
16
Since 2020
↗ View records
Avg Annual Salary
$129,659
All years combined
↗ View chart
Top Role
Clinical Research Associate
↗ Click to filter
Filing trend
H‑1B filings by year for Revance Therapeutics Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2023 | 1 | $120,931 |
| 2022 | 6 | $124,790 |
| 2021 | 9 | $133,874 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary